Ras is the name given to a family of related proteins which is ubiquitously expressed in all cell lineages and organs.All members of the Ras protein family are involved in signal transmission within cells and are members of the small GTPase protein class. Ras is the representative member of the Ras superfamily, a group of proteins that all share a common 3D structure and control a variety of cell behaviors. Incoming signals that activate Ras then activate other proteins, which in turn activate genes necessary for cell growth, differentiation, and survival. Ras proteins that are permanently activated can therefore be produced as a result of ras gene mutations.Even in the absence of incoming signals, this may result in unintended and excessive signaling within the cell. Overactive Ras signaling can ultimately result in cancer because these signals cause cell growth and division. The most prevalent oncogenes in human cancer are the 3 Ras genes (HRAS, KRAS, and NRAS), and Ras inhibitors are being researched as a potential treatment for cancer and other conditions characterized by Ras overexpression.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87119 | (+)-Oxanthromicin | 1616622-08-2 | (+)-Oxanthromicin (Compound 1) can mislocalize oncogenic mutant K-Ras from the plasma membrane in intact Madin-Darby canine kidney (MDCK) cells, thereby exerting antitumor activity. |
|
V121309 | (1R)-KRAS inhibitor-24 | 3030576-46-3 | (1R)-KRAS inhibitor-24 is a pyridopyrimidine KRAS inhibitor with an IC50 of < 100 nM for KRas G12V, KRas WT and KRas G12R. |
|
V110320 | (4R)-BBO-8520 | 2893809-52-2 | (4R)-BBO-8520 (compound 314) is an isomer of BBO-8520 and a selective KRASG12C inhibitor. |
|
V112413 | (R)-ACBI-4 | 3097973-97-9 | (R)-ACBI-4 is an isomer of ACBI-4. |
|
V103520 | (R)-G12Di-7 | 2946593-60-6 | (R)-G12Di-7 is a covalent ligand of KRAS-G12D and can selectively label K-Ras-G12D·GDP and K-Ras-G12D·GppNHp. |
|
V116937 | (R)-KRAS G12D inhibitor 28 hydrochloride dihydrate | 3081520-70-6 | (R)-KRAS G12D Inhibitor 28 Hydrochloride Dihydrate is the dihydrate of (R)-KRAS G12D Inhibitor 28. |
|
V109064 | (Rac)-Opnurasib | 2653201-38-6 | (Rac)-Opnurasib ((Rac)-JDQ-443; (Rac)-NVP-JDQ443) are racemic forms of Opnurasib. |
|
V89591 | (RS)-G12Di-1 | (RS)-G12Di-1 is a selective covalent inhibitor of K-Ras-G12D. | |
|
V118513 | (S)-AZD0022 | (S)-AZD0022 is an isomer of AZD0022, which is a selective orally active KRASG12D inhibitor. | |
|
V51415 | (S)-JDQ-443 ((S)-NVP-JDQ443) | 2653994-10-4 | (S)-JDQ-443 is an isomer of JDQ-443 . |
|
V122259 | (S,R,S)-BBO-11818 | 3029184-80-0 | (S,R,S)-BBO-11818 is a KRAS inhibitor that can be used in cancer research. |
|
V117719 | (±)-Spiro-oxanthromicin A | 1616622-10-6 | (±)-Spirocycloflavin A (compound 4) is a polyketide compound and a K-Ras inhibitor with an IC50 value of 26.7 μM. |
|
V51476 | CFL-137 | 708-06-5 | CFL-137 is a selective KRasG12C inhibitor. |
|
V51475 | CFL-120 | 18711-15-4 | CFL-120 is a selective KRasG12C inhibitor. |
|
V127486 | 6-Thio-GTP tetrasodium | 6-Thio-GTP tetrasodium is a Vav1-Rac inhibitor. | |
|
V87108 | 8-CPT-2'-O-Me-cAMP | 510774-50-2 | 8-CPT-2'-O-Me-cAMP is a Rap1 activator. |
|
V87118 | 8-pHPT-2'-O-Me-cAMP | 612513-15-2 | 8-pHPT-2'-O-Me-cAMP is a cAMP analog and an Epac agonist. |
|
V120117 | ACBI-4 | 3097985-19-5 | ACBI-4 is a selective GTP-bound KRAS active state (KRAS(on)) PROTAC degrader. |
|
V86758 | ADT-007 | 1945941-09-2 | ADT-007 is a potent, orally active pan-RAS inhibitor with strong anticancer effects. |
|
V128345 | ADT-1004 | 1945941-72-9 | ADT-1004 is the oral active prodrug of ADT-007. |